Sygrid van der Zee1,2, Martijn L T M Müller1,3, Prabesh Kanel1,3, Teus van Laar2, Nicolaas I Bohnen1,3,4,5. 1. Department of Radiology, University of Michigan, Ann Arbor, Michigan, USA. 2. Department of Neurology and Department of Neuropsychology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands. 3. Morris K. Udall Center of Excellence for Parkinson's Disease Research, University of Michigan, Ann Arbor, Michigan, USA. 4. Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA. 5. Neurology Service and Geriatric Research Education and Clinical Center (GRECC), Veterans Administration Ann Arbor Healthcare System, Ann Arbor, Michigan, USA.
Abstract
BACKGROUND: The cholinergic system plays a key role in cognitive impairment in Parkinson's disease (PD). Previous acetylcholinesterase positron emission tomography imaging studies found memory, attention, and executive function correlates of global cortical cholinergic losses. Vesicular acetylcholine transporter positron emission tomography allows for more accurate topographic assessment of not only cortical but also subcortical cholinergic changes. OBJECTIVE: The objectiveof this study was to investigate the topographic relationship between cognitive functioning and regional cholinergic innervation in patients with PD. METHODS: A total of 86 nondemented patients with PD (mean ± SD age 67.8 ± 7.6 years, motor disease duration 5.8 ± 4.6 years), and 12 healthy control participants (age 67.8 ± 7.8 years) underwent cholinergic [18 F]Fluoroethoxybenzovesamicol positron emission tomography imaging. Patients with PD underwent neuropsychological assessment. The z scores for each cognitive domain were determined using an age-matched, gender-matched, and educational level-matched control group. Correlations between domain-specific cognitive functioning and cholinergic innervation were examined, controlling for motor impairments and levodopa equivalent dose. Additional correlational analyses were performed using a mask limited to PD versus normal aging binding differences to assess for disease-specific versus normal aging effects. RESULTS: Voxel-based whole-brain analysis demonstrated partial overlapping topography across cognitive domains, with most robust correlations in the domains of memory, attention, and executive functioning (P < 0.01, corrected for multiple comparisons). The shared pattern included the cingulate cortex, insula/operculum, and (visual) thalamus. CONCLUSION: Our results confirm and expand on previous observations of cholinergic system involvement in cognitive functioning in PD. The topographic overlap across domains may reflect a partially shared cholinergic functionality underlying cognitive functioning, representing a combination of disease-specific and aging effects.
BACKGROUND: The cholinergic system plays a key role in cognitive impairment in Parkinson's disease (PD). Previous acetylcholinesterase positron emission tomography imaging studies found memory, attention, and executive function correlates of global cortical cholinergic losses. Vesicular acetylcholine transporter positron emission tomography allows for more accurate topographic assessment of not only cortical but also subcortical cholinergic changes. OBJECTIVE: The objectiveof this study was to investigate the topographic relationship between cognitive functioning and regional cholinergic innervation in patients with PD. METHODS: A total of 86 nondemented patients with PD (mean ± SD age 67.8 ± 7.6 years, motor disease duration 5.8 ± 4.6 years), and 12 healthy control participants (age 67.8 ± 7.8 years) underwent cholinergic [18 F]Fluoroethoxybenzovesamicol positron emission tomography imaging. Patients with PD underwent neuropsychological assessment. The z scores for each cognitive domain were determined using an age-matched, gender-matched, and educational level-matched control group. Correlations between domain-specific cognitive functioning and cholinergic innervation were examined, controlling for motor impairments and levodopa equivalent dose. Additional correlational analyses were performed using a mask limited to PD versus normal aging binding differences to assess for disease-specific versus normal aging effects. RESULTS: Voxel-based whole-brain analysis demonstrated partial overlapping topography across cognitive domains, with most robust correlations in the domains of memory, attention, and executive functioning (P < 0.01, corrected for multiple comparisons). The shared pattern included the cingulate cortex, insula/operculum, and (visual) thalamus. CONCLUSION: Our results confirm and expand on previous observations of cholinergic system involvement in cognitive functioning in PD. The topographic overlap across domains may reflect a partially shared cholinergic functionality underlying cognitive functioning, representing a combination of disease-specific and aging effects.
Authors: Bart Post; Dino Muslimovic; Nan van Geloven; Johannes D Speelman; Ben Schmand; Rob J de Haan Journal: Mov Disord Date: 2011-02-10 Impact factor: 10.338
Authors: N I Bohnen; D I Kaufer; R Hendrickson; L S Ivanco; B J Lopresti; G M Constantine; Ch A Mathis; J G Davis; R Y Moore; S T Dekosky Journal: J Neurol Date: 2005-09-02 Impact factor: 4.849
Authors: Myria Petrou; Kirk A Frey; Michael R Kilbourn; Peter J H Scott; David M Raffel; Nicolaas I Bohnen; Martijn L T M Müller; Roger L Albin; Robert A Koeppe Journal: J Nucl Med Date: 2014-01-30 Impact factor: 10.057
Authors: Nicolaas I Bohnen; Martijn L T M Müller; Vikas Kotagal; Robert A Koeppe; Michael R Kilbourn; Sid Gilman; Roger L Albin; Kirk A Frey Journal: J Cereb Blood Flow Metab Date: 2012-05-09 Impact factor: 6.200
Authors: Janne M Papma; Marion Smits; Marius de Groot; Francesco U Mattace Raso; Aad van der Lugt; Henri A Vrooman; Wiro J Niessen; Peter J Koudstaal; John C van Swieten; Frederik M van der Veen; Niels D Prins Journal: Eur Radiol Date: 2017-03-13 Impact factor: 5.315
Authors: Rachael A Lawson; Alison J Yarnall; Gordon W Duncan; Tien K Khoo; David P Breen; Roger A Barker; Daniel Collerton; John-Paul Taylor; David J Burn Journal: Parkinsonism Relat Disord Date: 2014-07-18 Impact factor: 4.891
Authors: Seok Jong Chung; Han Soo Yoo; Hye Sun Lee; Yang Hyun Lee; KyoungWon Baik; Jin Ho Jung; Byoung Seok Ye; Young H Sohn; Phil Hyu Lee Journal: J Neurol Date: 2021-05-04 Impact factor: 4.849
Authors: Nicolaas I Bohnen; Alison J Yarnall; Rimona S Weil; Elena Moro; Mark S Moehle; Per Borghammer; Marc-André Bedard; Roger L Albin Journal: Lancet Neurol Date: 2022-02-04 Impact factor: 44.182
Authors: Roger L Albin; Sygrid van der Zee; Teus van Laar; Martin Sarter; Cindy Lustig; Martijn L T M Muller; Nicolaas I Bohnen Journal: Prog Brain Res Date: 2022-02-04 Impact factor: 2.453
Authors: Trina Mitchell; Stéphane Lehéricy; Shannon Y Chiu; Antonio P Strafella; A Jon Stoessl; David E Vaillancourt Journal: JAMA Neurol Date: 2021-10-01 Impact factor: 29.907
Authors: Peter S Myers; John L O'Donnell; Joshua J Jackson; Christina N Lessov-Schlaggar; Rebecca L Miller; Erin R Foster; Carlos Cruchaga; Bruno A Benitez; Paul T Kotzbauer; Joel S Perlmutter; Meghan C Campbell Journal: Neurology Date: 2022-04-13 Impact factor: 11.800
Authors: Nicolaas I Bohnen; Prabesh Kanel; Robert A Koeppe; Carlos A Sanchez-Catasus; Kirk A Frey; Peter Scott; Gregory M Constantine; Roger L Albin; Martijn L T M Müller Journal: Brain Commun Date: 2021-05-22
Authors: Prabesh Kanel; Sygrid van der Zee; Carlos A Sanchez-Catasus; Robert A Koeppe; Peter J H Scott; Teus van Laar; Roger L Albin; Nicolaas I Bohnen Journal: Aging Brain Date: 2022-03-28